Morning Blend


Bayer | 12/20/18

Posted at 1:45 PM, Dec 20, 2018
and last updated 2018-12-20 16:45:59-05

TRK Fusion Cancer, is a rare form cancer that can affect both adults and children. This morning, we look at new advances in treatment that fight the disease and how genomic testing is changing the way cancer is looked at!

For more information, visit

This segment is sponsored by Bayer